Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06181643 · ClinicalTrials.gov registry record · NA

Innovating CBT-I for Cancer Survivors: An Optimization Trial

A NA study of Insomnia and Cancer Survivorship, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06181643 is a NA study of Insomnia and Cancer Survivorship that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06181643, a NA study of Insomnia and Cancer Survivorship, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this project is to conduct a factorial, randomized controlled trial to optimize synchronous, virtual delivery of CBT-I for cancer survivors. The proposed project will yield multiple deliverables to innovate cancer survivorship care, chiefly an optimized, scalable, virtually-delivered intervention that addresses chronic insomnia, one of the most deleterious concerns among the growing demographic of cancer survivors in the U.S. Findings will inform future considerations for delivering CBT-I to cancer survivors.

Conditions Studied

Insomnia Cancer Survivorship

Interventions

  • BEHAVIORAL Survivorship Sleep Program with Individual Delivery + No Booster Sessions
  • BEHAVIORAL Survivorship Sleep Program with Group Delivery + No Booster Sessions
  • BEHAVIORAL Survivorship Sleep Program with Individual Delivery + 3 Booster Sessions
  • BEHAVIORAL Survivorship Sleep Program with Group Delivery + 3 Booster Sessions

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-09-06
Est. Completion 2026-05-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06181643

The ClinicalTrials.gov registry entry for NCT06181643 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (53% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 4 interventions - of which Survivorship Sleep Program with Individual Delivery + No Booster Sessions is the first listed.

NCT06181643 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06181643 about?

NCT06181643 is a clinical study titled "Innovating CBT-I for Cancer Survivors: An Optimization Trial". The overall goal of this project is to conduct a factorial, randomized controlled trial to optimize synchronous, virtual delivery of CBT-I for cancer survivors. The proposed project will yield multiple deliverables to innovate cancer survivorship care, chiefly an optimized, scalable, virtually-deliv...

What is the current status of trial NCT06181643?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-09-06. Estimated completion is 2026-05-31.

What conditions does trial NCT06181643 study?

This clinical trial studies the following conditions: Insomnia, Cancer Survivorship.

What interventions are being tested in trial NCT06181643?

The interventions under investigation include: Survivorship Sleep Program with Individual Delivery + No Booster Sessions (BEHAVIORAL), Survivorship Sleep Program with Group Delivery + No Booster Sessions (BEHAVIORAL), Survivorship Sleep Program with Individual Delivery + 3 Booster Sessions (BEHAVIORAL), Survivorship Sleep Program with Group Delivery + 3 Booster Sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06181643?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06181643 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insomnia

All registered trials for this condition

Cancer Survivorship

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.